Standard BioTools Inc.
Cash Flow Statement
| Line Item | Jun 2026 | Mar 2026 | Sep 2025 | Jun 2025 | Mar 2025 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-26.8M | $127.1M | $-34.7M | $-33.5M | $-26.0M | $-26.9M | $-45.7M | $-32.2M |
| Depreciation & Amortization | — | $1.4M | — | — | $3.3M | $3.9M | $3.9M | $5.2M |
| Depreciation | — | $1.4M | $1.5M | $2.0M | $2.1M | $1.0M | $1.0M | $3.0M |
| Amortization | — | $0 | — | — | $898.0K | — | — | $2.1M |
| Stock-Based Compensation | — | $8.8M | — | — | $9.0M | — | — | $11.6M |
| Net Cash from Operating Activities | $-10.3M | $-46.6M | $-22.2M | $-20.7M | $-30.3M | $-27.9M | $-39.1M | $-62.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $344.0K | $570.0K | $886.0K | $1.9M | $5.1M | $2.3M | $1.9M | $781.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | — | $191.1M | — | — | $14.6M | — | — | $318.1M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | $0 | — | — | $11.1M |
| Net Cash from Financing Activities | — | $-40.0K | — | — | $-46.0K | — | — | $-19.7M |
| Net Change in Cash | — | $144.6M | — | — | $-15.3M | — | — | $235.8M |
| Free Cash Flow | $-10.7M | $-47.2M | $-23.1M | $-22.6M | $-35.3M | $-30.1M | $-41.0M | $-63.3M |